‘To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/nerandomilast-may-have-mortality-benefit-patients-autoimmune-2026a1000e07?src=rss
Author :
Publish date : 2026-05-01 13:56:00
Copyright for syndicated content belongs to the linked Source.
